salsoline has been researched along with selegiline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dostert, P; Hashizume, Y; Kasamatsu, T; Kohda, K; Maruyama, W; Naoi, M; Takahashi, T | 1 |
| Maruyama, W; Naoi, M; Yagi, K; Youdim, M | 1 |
| Akao, Y; Maruyama, W; Nakagawa, Y; Naoi, M; Takahashi, T | 1 |
| Maruyama, W; Naoi, M | 1 |
4 other study(ies) available for salsoline and selegiline
| Article | Year |
|---|---|
An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
Topics: Antioxidants; Apoptosis; Carcinogens; Catalase; Cycloheximide; DNA Damage; Dopamine; Free Radicals; Humans; Microscopy, Fluorescence; Neuroblastoma; Neuroprotective Agents; Neurotoxins; Oxidation-Reduction; Parkinson Disease; Protein Synthesis Inhibitors; Salsoline Alkaloids; Selegiline; Semicarbazides; Stereoisomerism; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1997 |
Anti-apoptotic function of L-(-)deprenyl (Selegiline) and related compounds.
Topics: Antioxidants; Antiparkinson Agents; Apoptosis; DNA Damage; DNA Fragmentation; Humans; Neurotoxins; Parkinson Disease; Salsoline Alkaloids; Selegiline; Structure-Activity Relationship; Tetrahydroisoquinolines; Tumor Cells, Cultured | 2000 |
Involvement of endogenous N-methyl(R)salsolinol in Parkinson's disease: induction of apoptosis and protection by (-)deprenyl.
Topics: Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Dopamine; Enzyme Activation; Female; Humans; Male; Neuroprotective Agents; Oligopeptides; Parkinson Disease; Salsoline Alkaloids; Selegiline; Tetrahydroisoquinolines; Tumor Cells, Cultured | 2000 |
Future of neuroprotection in Parkinson's disease.
Topics: Apoptosis; Humans; Molsidomine; Neuroprotective Agents; Neurotoxins; Nitric Oxide Donors; Oxidopamine; Parkinson Disease; Propylamines; Salsoline Alkaloids; Selegiline; Tetrahydroisoquinolines; Tumor Cells, Cultured | 2001 |